Antibacterial drugs: Clinical development for non-developers
Part 1: Traditional development – tiers A and B

NEW: Download a summary of this webinar here!

Speaker: David Shlaes – Anti-infectives consulting, retired

Moderator: Laura Piddock – Head of Scientific Affairs, GARDP

In this presentation we introduce the relationship between the discovery phase and later clinical development. We discuss in some depth traditional clinical development pathways (tiers A and B) focusing on the non-inferiority trial design.


We hosted this live webinar with David Shlaes and Laura Piddock on 13 June 2018.

If you have questions or comments, please let us know: revive@gardp.org.

2020-12-18T12:15:29+00:00